DENVER, Oct. 20 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global Med") (OTC:GLOB) (BULLETIN BOARD: GLOB) , an international e-Health, medical information technology company, will be presenting at the Rodman & Renshaw 10th Annual Healthcare Conference to be held November 10-12, 2008, at the New York Palace Hotel in New York City. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) On Monday, November 10, at 2:50 p.m. EST, Dr. Mick Ruxin, Chief Executive Officer of Global Med Technologies, will give a 20-minute presentation in the Holmes I Room (4th floor), regarding Global Med's business, unique value proposition, latest developments, financial performance and future prospects. Management will also participate in a 10-minute question and answer session following the presentation and in one-on-one meetings throughout the day. Last year's Rodman & Renshaw Healthcare Conference included over 350 presenting companies and over 2,500 attendees, as well as attendance of experts from the medical, scientific and investment communities. The categories of presentation include autoimmune diseases, cardiovascular diseases, CNS, drug delivery, gene therapy, infectious diseases, medical devices, oncology, specialty pharmaceuticals, and therapeutic vaccines. A vast number of institutional investors, venture capitalists, private investors, industry executives, scientists and other industry leaders are expected to attend this year's healthcare conference. About Global Med Technologies, Inc. Global Med Technologies(R), Inc. is an international medical software company which develops regulated and non-regulated software products and services for the healthcare industry. As a leading provider of blood and laboratory software applications and services, Global Med's products are deployed in 20 countries and serve over 1,600 transfusion centers, blood banks and laboratories. Global Med's U.S. division, Wyndgate Technologies(R), provides Vein-to-Vein(R) tracking through its Donor Doc(TM), SafeTrace(R), SafeTrace Tx(R) and ElDorado Donor(TM) software products. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Global Med's European subsidiary, Inlog, SA, is a leading provider of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally. Inlog's products include EdgeBlood*, EdgeTrack*, EdgeCell, EdgeLab and SAPANET. Global Med's U.S. division, eDonor(R), provides a web-based donor relationship management system that integrates recruitment, scheduling, retention and fulfillment for national as well as local community blood centers and hospitals. eDonor's products and services are designed to complement Global Med's strong line of international blood management and laboratory information software and service solutions. Global Med's U.S. subsidiary, PeopleMed(R), Inc., provides cost-effective customized software validation, consulting and compliance solutions to hospitals and donor centers. For more information about Global Med's products and services, please call 800-996-3428 or visit http://www.globalmedtech.com/, http://www.peoplemed.com/, http://www.inlog.com/, http://www.edonor.com/, and http://www.wyndgate.com/. *FDA 510(k) clearance required prior to sales in the U.S. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies, Inc., +1-303-238-2000, ; or Investors, Paul Holm, President of portfolio pr, +1-212-888-4570, , for Global Med Technologies, Inc. Web Site: http://www.edonor.com/ http://www.globalmedtech.com/ http://www.inlog.com/ http://www.peoplemed.com/ http://www.wyndgate.com/

Copyright